Furthermore, our findings demonstrate the translatability of NFE2 and PF4 from preclinical to clinical settings, making them valuable tools for predicting and monitoring thrombocytopenia, and potentially anemia. The gene discussed is PF4; the disease is Thrombocytopenia.